Here is why Eli Lilly (LLY) is Among the 8 Best Beginner Stocks to Buy Right Now [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
On April 15, 2026, Eli Lilly and Company (NYSE:LLY) reported topline results from the Phase 3 ACHIEVE-4 trial evaluating Foundayo against insulin glargine in adults with type 2 diabetes who are overweight or obese and at elevated cardiovascular risk. The study enrolled more than 2,700 participants across 15 countries and met its primary endpoint, demonstrating non-inferiority in major adverse cardiovascular events, including cardiovascular death, heart attack, stroke, or hospitalization for unstable chest pain. Foundayo also delivered superior reductions in A1C and body weight at 52 weeks versus insulin glargine, with benefits sustained through 104 weeks. The treatment showed a 16% lower risk of major cardiovascular events and a 57% lower risk of all-cause death, though the latter was not adjusted for multiplicity. Here is why Eli Lilly (LLY) is Among the 8 Best Beginner Stocks to Buy Right Now Improvements were also observed across cardiovascular risk markers such as non-HDL cho
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Novo Nordisk: Is The GLP-1 Golden Age Already Behind It? [Seeking Alpha]Seeking Alpha
- Neuroblastoma Treatment Market Analysis Report 2025-2035 - Regional Players and Local Manufacturers are Expected to Play an Important Role in Future Growth [Yahoo! Finance]Yahoo! Finance
- Samsung Biologics Reports First Quarter 2026 Financial Results [TheStreet.com]TheStreet.com
- Eli Lilly's Kelonia Therapeutics acquisition seen as strategic bet on next-generation CAR-T: analysts [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's US$7b Kelonia Deal Reshapes Oncology And Valuation Story [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 4/21/26 - Form 4
- 4/21/26 - Form 4
- 4/21/26 - Form 4
- LLY's page on the SEC website